2-[2-Bromo-5-(tert-butyl-dimethyl-silanyloxy)-benzyl]-isoindole-1,3-dione | 478541-58-1

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 异吲哚及其衍生物
• 英文名称: 2-[2-Bromo-5-(tert-butyl-dimethyl-silanyloxy)-benzyl]-isoindole-1,3-dione
• 英文别名: 2-[[2-bromo-5-[tert-butyl(dimethyl)silyl]oxyphenyl]methyl]isoindole-1,3-dione
• CAS: 478541-58-1
• 化学式: C₂₁H₂₄BrNO₃Si
• 分子量: 446.416
• InChiKey: VLZSRYVWUJKBIC-UHFFFAOYSA-N

物化性质

• 沸点：
  483.6±45.0 °C(Predicted)
• 密度：
  1.315±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  5.63
• 重原子数：
  27
• 可旋转键数：
  5
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  46.6
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  2-[2-Bromo-5-(tert-butyl-dimethyl-silanyloxy)-benzyl]-isoindole-1,3-dione 在 palladium diacetate 、 四丁基氟化铵 、 N,N-二异丙基乙胺 、 三(邻甲基苯基)磷 作用下， 以 四氢呋喃 为溶剂， 生成 tert-butyl (E)-3-[2-[(1,3-dioxoisoindol-2-yl)methyl]-4-hydroxyphenyl]prop-2-enoate
  参考文献：
  名称：

  Synthesis and evaluation of aminomethyl dihydrocinnamates as a new class of PPAR ligands

  摘要：

  PPAR ligands with varied subtype selectivity have been synthesized using an achiral aminomethyl dihydrocinnamate template. Several compounds in this series have demonstrated potent plasma glucose and triglyceride lowering capability in rodent models of type 2 diabetes. (c) 2006 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2006.09.011
• 作为产物：
  描述：

  4-溴-3-甲基苯酚 在 N-溴代丁二酰亚胺(NBS) 、 偶氮二异丁腈 、 TEA 作用下， 以 二氯甲烷 、 1,2-二氯乙烷 、 N,N-二甲基甲酰胺 为溶剂， 生成 2-[2-Bromo-5-(tert-butyl-dimethyl-silanyloxy)-benzyl]-isoindole-1,3-dione
  参考文献：
  名称：

  Synthesis and evaluation of aminomethyl dihydrocinnamates as a new class of PPAR ligands

  摘要：

  PPAR ligands with varied subtype selectivity have been synthesized using an achiral aminomethyl dihydrocinnamate template. Several compounds in this series have demonstrated potent plasma glucose and triglyceride lowering capability in rodent models of type 2 diabetes. (c) 2006 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2006.09.011

文献信息

• Modulators of peroxisome proliferator activated receptors (ppar)
  申请人：Gossett Stacy Lynn

  公开号：US20050075378A1

  公开（公告）日：2005-04-07

  The present invention is directed to a compound of formula I, and pharmaceutically acceptable salts, solvates, hydrates or stereoisomer thereof, which are useful in treating Syndrome X, Type II diabetes, hyperglycemia, hyperlipidemia, obesity, coagaulopathy, hypertension, arteriosclerosis, and other disorders related to Syndrome X as well as cardiovascular diseases.

  本发明涉及一种I式化合物，以及其药学上可接受的盐、溶剂、水合物或立体异构体，该化合物在治疗X综合征、2型糖尿病、高血糖、高脂血症、肥胖症、凝血障碍、高血压、动脉硬化以及与X综合征相关的其他疾病以及心血管疾病方面有用。
• Modulators of peroxisome proliferator activated receptors (PPAR)
  申请人：Eli Lilly and Company

  公开号：US07282501B2

  公开（公告）日：2007-10-16

  The present invention is directed to a compound of formula I, and pharmaceutically acceptable salts, solvates, hydrates or stereoisomer thereof, which are useful in treating Syndrome X, Type II diabetes, hyperglycemia, hyperlipidemia, obesity, coagaulopathy, hypertension, arteriosclerosis, and other disorders related to Syndrome X as well as cardiovascular diseases.

  本发明涉及一种I式化合物，以及其药学上可接受的盐，溶剂合物，水合物或立体异构体，该化合物可用于治疗X综合征，2型糖尿病，高血糖，高脂血症，肥胖症，凝血障碍，高血压，动脉硬化以及与X综合征相关的其他疾病，以及心血管疾病。
• MODULATORS OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTORS (PPAR)
  申请人：Gossett Lynn Stacy

  公开号：US20080167310A1

  公开（公告）日：2008-07-10

  The present invention is directed to a compound of formula I, and pharmaceutically acceptable salts, solvates, hydrates or stereoisomer thereof, which are useful in treating Syndrome X, Type II diabetes, hyperglycemia, hyperlipidemia, obesity, coagaulopathy, hypertension, arteriosclerosis, and other disorders related to Syndrome X as well as cardiovascular diseases.

  本发明涉及公式I的化合物及其药学上可接受的盐、溶剂化合物、水合物或立体异构体，其可用于治疗X综合症、II型糖尿病、高血糖、高血脂、肥胖症、凝血异常、高血压、动脉硬化以及与X综合症和心血管疾病有关的其他疾病。
• Synthesis and evaluation of aminomethyl dihydrocinnamates as a new class of PPAR ligands
  作者：Alan M. Warshawsky、Charles A. Alt、Joseph T. Brozinick、Allen R. Harkness、Eric D. Hawkins、James R. Henry、Donald P. Matthews、Anne R. Miller、Elizabeth A. Misener、Chahrzad Montrose-Rafizadeh、Gary A. Rhodes、Quanrong Shen、Jennifer A. Vance、Uko E. Udodong、Minmin Wang、Tony Y. Zhang、Richard W. Zink

  DOI：10.1016/j.bmcl.2006.09.011

  日期：2006.12

  PPAR ligands with varied subtype selectivity have been synthesized using an achiral aminomethyl dihydrocinnamate template. Several compounds in this series have demonstrated potent plasma glucose and triglyceride lowering capability in rodent models of type 2 diabetes. (c) 2006 Elsevier Ltd. All rights reserved.